Molecular Pathways: Targeting Resistance in the Androgen Receptor for Therapeutic Benefit

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-12-3601
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Mechanisms of Acquired Resistance to Androgen Receptor Targeting Drugs in Castration-Resistant Prostate Cancer

Expert Review of Anticancer Therapy
OncologyPharmacology
2014English

Redefining Androgen Receptor Function: Clinical Implications in Understanding Prostate Cancer Progression and Therapeutic Resistance

2016English

Molecular Defects of the Androgen Receptor

Recent Progress in Hormone Research
2002English

Targeting Androgen-Independent Pathways: New Chances for Patients With Prostate Cancer?

Critical Reviews in Oncology/Hematology
GerontologyGeriatricsHematologyOncology
2017English

Molecular Basis of Androgen Resistance in a Family With a Qualitative Abnormality of the Androgen Receptor and Responsive to High-Dose Androgen Therapy.

Journal of Clinical Investigation
Medicine
1991English

Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer

Scientific Reports
Multidisciplinary
2017English

The Androgen Receptor and Signal-Transduction Pathways in Hormone-Refractory Prostate Cancer. Part 1: Modifications to the Androgen Receptor

BJU International
Urology
2005English

Trinucleotide Repeats in the Human Androgen Receptor: A Molecular Basis for Disease

Journal of Molecular Endocrinology
EndocrinologyMolecular Biology
1998English

Tubulin-Targeting Chemotherapy Impairs Androgen Receptor Activity in Prostate Cancer

Cancer Research
Cancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy